Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-023007-10-SE
EUCTR2010-023007-10-SE
Active, not recruiting
Not Applicable

A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response

ppsala university0 sitesJanuary 5, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMen and women diagnosed with DSM-IV social phobia (social anxiety disorder)MedDRA version: 14.0Level: LLTClassification code 10041242Term: Social anxiety disorderSystem Organ Class: 10037175 - Psychiatric disorders
DrugsCipralex

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Men and women diagnosed with DSM-IV social phobia (social anxiety disorder)
Sponsor
ppsala university
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 5, 2011
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
ppsala university

Eligibility Criteria

Inclusion Criteria

  • •1\. Social anxiety disorder (social phobia), according to DSM\-IV, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders
  • •2\. Otherwise somatically healthy
  • •3\. Age 18 or older but not postmenopausal
  • •4\. Willingness to participate in a symptom provocation brain imaging trial
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\. Treatment of social anxiety within the three months preceding the study
  • •2\. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g., psychosis, major depressive disorder, bipolar disorder)
  • •3\. Suicidal ideation
  • •4\. Chronic use of prescribed medication that could influence the results
  • •5\. Abuse of alcohol or narcotics
  • •6\. Pregnancy or planned pregnancy during the study period
  • •7\. Menopause
  • •8\. Previous PET examination
  • •9\. Contrainidications for MRI investigations (e.g. implants or other metal objects in the body, brain and heart operations)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A neuroscience perspective on anxiety proneness - sex differences, monoaminergic pathways and treatment responseSocial anxiety disorder (social phobia)Mental and Behavioural DisordersSocial phobia
ISRCTN24929928ppsala University (Sweden)96
Completed
Not Applicable
Evaluation of brain activity in anxiety related region using MRI: validation study for psycho-oncologyHealthy individuals
JPRN-UMIN000006771ational Institute of Radiological Sciences20
Recruiting
Not Applicable
De rol van emotionele factoren op het hebben van lichamelijke klachteSymptom somatic disorder
NL-OMON22895Zuyderland Medisch CentrumAfdeling klinische en medische psychologie90
Active, not recruiting
Phase 1
RESOLVING THE NEUROBIOLOGICAL MECHANISMS OF ANXIETY DISORDERS – BRAIN IMAGING SUB-STUDY
EUCTR2014-005366-30-FIniversity of Helsinki
Recruiting
Not Applicable
Revealing individual neural underpinnings of anxiety in healthy subjectsanxiety10002861
NL-OMON44325Radboud Universiteit Nijmegen250